Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Silexion Therapeutics (NASDAQ:SLXN) Advances SIL204 Toward Phase 2/3 Pancreatic Cancer Trial

Silexion Therapeutics Corp. (NASDAQ:SLXN) has announced an important milestone with the successful completion of toxicology studies for SIL204, a next-generation RNA-silencing therapy developed to target mutated KRAS oncogenes. Pancreatic cancer continues to be one of the deadliest malignancies, with limited treatment choices and exceptionally …

Team Kalkine | 27 November 2025

Federal Signal (NYSE:FSS) Expands Specialty Vehicle Portfolio Through New Acquisition

Federal Signal Corp. (NYSE:FSS) announced the completion of its previously disclosedacquisitionof Scranton Manufacturing Company LLC, widely known as New Way Trucks. The Iowa-based company is a major U.S. designer and manufacturer of refuse collection vehicles, a category that aligns closely with Federal Signal’s existing …

Team Kalkine | 27 November 2025

GE HealthCare (NASDAQ:GEHC): New Pristina Recon DL Technology Enhances Mammography Imaging

GE HealthCare Technologies, Inc. (NASDAQ:GEHC) has receivedFDAPremarket Authorization for Pristina Recon DL, a next-generation 3D mammography image reconstruction solution. This milestone highlights the company’s continuedinvestmentinAI-driven technologies designed to enhance diagnostic accuracy in breast imaging.

Team Kalkine | 27 November 2025

Amber International (NYSE:AMBR) Reveals Share Buyback as Q3 Metrics Improve

Amber International Holding Limited (NYSE:AMBR) announced that its Board of Directors has approved a share repurchase program valued at up to USD 50 mln. Thebuybackinitiative will target the company’s outstanding American Depositary Sharee and will extend over a 12-month period beginning December 1, 2025.

Team Kalkine | 27 November 2025

Toyota Motor (NYSE:TM) Reports Growth in Worldwide Output and Sales for October

Toyota Motor Corp. (NYSE:TM) announced an increase in worldwide production for October, signaling healthy activity across its manufacturing network despite varied performance among itssubsidiaries. The automaker reported that global output rose 3.1 percentyear-over-yearto 1.05 million units. Production in Japan reached 415,331 units, reflecting a …

Team Kalkine | 27 November 2025

Wipro (NYSE:WIT) Teams Up with IISc For Advanced AI and Quantum Research

Wipro Limited (NYSE:WIT) has announced a prominent collaboration with the Indian Institute of Science and the Foundation for Science Innovation and Development to accelerate advancements in frontier technologies. This agreement represents a meaningful step in Wipro’s broader plan to deepen its research initiatives and …

Team Kalkine | 27 November 2025

Is Jefferies’ Revised View Signalling a Shift for Best Buy (NYSE:BBY)?

Jefferies Financial Group revised its target price for Best Buy(NYSE:BBY), lowering it from USD 95 to USD 94 in a research update released on Tuesday. The brokerage continues to assign abuyrating on the retailer’s shares. The revision comes amid varied analyst opinions recorded over …

Aditi Sarkar | 26 November 2025

Global Water Resources (NASDAQ:GWRS) Continues Consistent Dividend Policy

Global Water Resources, Inc. (NASDAQ:GWRS), a pure-play water resource management company, has declared a monthly cashdividendof USD 0.02533 per common share, translating to an annual dividend rate of USD 0.30396 per share. The dividend will be payable on December 30, 2025, toshareholdersof record at …

Team Kalkine | 26 November 2025

Microbot Medical (NASDAQ:MBOT) Debuts Endovascular Robotic System at Emory Hospital

Microbot Medical Inc. (NASDAQ:MBOT) announced that Emory University Hospital in Atlanta is the first hospital worldwide to adopt its LIBERTY® Endovascular Robotic System. LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system designed for peripheral endovascular procedures. It enables precise navigation within vascular …

Team Kalkine | 26 November 2025

CollPlant (NASDAQ:CLGN) Advances Aesthetic and Regenerative Portfolio in Q3 2025 Update

CollPlant Biotechnologies (NASDAQ:CLGN) reported its third-quarter 2025 financial results, highlighting scientific progress, commercial expansion and ongoing program development. The company’s proprietary non-animal recombinant human collagen (rhCollagen) continues to gain recognition as an ethical, sustainable and high-performance alternative for use across tissue engineering, aesthetics and …

Team Kalkine | 26 November 2025
Support

Hi! How can we help you today?

Loading…